Commitments and Contingencies [Abstract] Company contributions (in Dollars) Defined Contribution Plan, Employer Discretionary Contribution Amount Employer matching contributions, percentage Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Employee’s eligible compensation Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Commitments and Contingencies [Line Items] Purchase of additional warrants Purchase Of Additional Warrants Number of additional warrants purchased. Series A-2 Preferred Stock [Member] Series A-2 Prime Preferred Stock Series A2 Preferred Stock Member Series A-2 Prime Preferred Stock [Member] Series A-2 Prime Preferred Stock Series A2 Prime Preferred Stock Member Series A-3 Warrants and Received [Member] Series A3 Warrants And Received Member Series B-2 Preferred Stock [Member] Series B-2 Preferred Stock Series B2 Preferred Stock Member Series B Convertible Preferred Stock [Member] Series BConvertible Preferred Stock Member Stockholders’ Equity (Details) [Table] Class of Stock [Domain] Sale of Stock [Axis] Common Stock [Member] Common Stock Common Stock [Member] IPO [Member] IPO [Member] Common stock, par value (in Dollars per share) Common Stock, Par or Stated Value Per Share Class of Warrant or Right [Axis] Warrant [Member] Warrants [Member] Warrant liability [Member] Warrants to purchase common stock [Member] Common stock, shares authorized Common stock, shares authorized (in Shares) Common Stock, Shares Authorized Shares of common stock Auto-conversion preferred shares Conversion of Series A-2 Prime preferred stock into common stock (in Shares) Conversion of Stock, Shares Converted Conversion of the shares series preferred stock Convertible Preferred Stock, Shares Issued upon Conversion Shares warrants Acquired warrant shares Warrant acquired shares Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants term Warrants and Rights Outstanding, Term Number of Shares Underlying Outstanding Warrants, Warrants exercised Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Exercised in Period The number of exercised made during the period on other than stock (or unit) option plans Weighted- Average Exercise Price, Warrants exercised Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments other than Options Exercised in Period Weighted Average Grant Date Fair Value he weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock. Weighted- Average Remaining Contractual Term (in Years), Warrants exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Remaining Contractual Termin Years Warrants Exercised Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Aggregate Intrinsic Value, Warrants exercised Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Warrants Exercised Intrinsic value of outstanding award under Warrants exercised. Excludes share and unit options. Equity Component [Domain] Sale of Stock [Domain] Equity Components [Axis] Preferred Stock [Member] Preferred Stock [Member] Class of Warrant or Right [Domain] Stockholders’ Equity Deficit [Line Items] Proceeds of warrants (in Dollars) Proceeds from Issuance of Warrants Convertible debt shares granted Conversion of Stock, Shares Issued Common stock share issued Common stock, shares issued (in Shares) Common stock shares issued Common Stock, Shares, Issued Common stock price (in Dollars per share) Share issued price per share Shares Issued, Price Per Share Exercise price per warrant (in Dollars per share) Warrants exercise price (in Dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Amended Tranche B Warrants [Member] Amended Tranche BWarrants Member Aggregate shares Aggregate Shares Aggregate shares. Class of Warrant or Right [Table] Number of Shares Underlying Outstanding Warrants, Warrants granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Weighted- Average Remaining Contractual Term (in Years), Warrants granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Remaining Contractual Termin Years Warrants Granted Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Number of Shares Underlying Outstanding Warrants, Outstanding at Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted- Average Remaining Contractual Term (in Years), Outstanding at Ending Weighted- Average Remaining Contractual Term (in Years), Outstanding at Beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted-Average Remaining Contractual Term Schedule Of Activity For The Company SIpo Warrants Abstract Schedule of Activity for the Company’s IPO Warrants [Line Items] Stock-Based Compensation [Line Items] Schedule of Activity for Stock Options [Line Items] Weighted- Average Exercise Price, Warrants granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Aggregate Intrinsic Value, Warrants granted Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Warrants Granted Intrinsic value of outstanding award under warrants granted. Excludes share and unit options. Weighted- Average Exercise Price, Outstanding at Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Aggregate Intrinsic Value, Outstanding at Ending Aggregate Intrinsic Value, Outstanding at Ending Aggregate Intrinsic Value, Outstanding at Beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Stockholders’ Equity [Abstract] Class of Stock [Axis] Designated shares Preferred stock, shares authorized (in Shares) Preferred Stock, Shares Authorized Aggregate fair value (in Dollars) Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Original price per share (in Dollars per share) Original Price Per Share Original price per share. Description of convertible shares Preferred Stock, Convertible, Terms Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Abstract] Series B-1 Preferred Stock [Member] Series B1 Convertible Preferred Stock Member Number of share issued Shares sold (in Shares) Sale of Stock, Number of Shares Issued in Transaction Initial carrying value (in Dollars) Initial Carrying Value Initial carrying value. Preferred stock outstanding Preferred stock, shares outstanding (in Shares) Preferred Stock, Shares Outstanding Tranche B Warrant [Member] Tranche BWarrant Member Agent fees and offering expenses (in Dollars) Transfer Agent and Custodian Fees Vesting [Domain] Annual dividend rate Preferred Stock, Dividend Rate, Percentage Outstanding common stock percentage Outstanding Common Stock Percentage Outstanding common stock percentage. Voting rights of preferred stock Preferred Stock, Voting Rights Series A-3 Preferred Stock [Member] Series A-3 Preferred Stock Series A3 Preferred Stock Member Series A-5 Preferred Stock [Member] Series A5 Preferred Stock Member Vesting [Axis] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Plan Name [Domain] Related and Nonrelated Parties [Axis] 2021 Plan [Member] Two Thousand Twenty One Plan Member Related and Nonrelated Parties [Domain] Stock Options [Member] Equity Option [Member] Common stock shares reserved for issuance Common Stock, Capital Shares Reserved for Future Issuance Percentage of increase provision Percentage Of Increase Provision Percentage of increase provision. Schedule Of Preferred Stock Warrants Abstract Document Period End Date Document Fiscal Period Focus Derivative Contract [Domain] Warrant Liability [Line Items] Fair value of warrants Adjustment of Warrants Granted for Services Stock-Based Compensation [Abstract] Plan Name [Axis] Number of Shares Underlying Outstanding Options, Options forfeited (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Number of Shares Underlying Outstanding Options granted (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Weighted-Average Exercise Price, Options granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-Average Exercise Price, Options forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Restricted Stock Units (RSUs) [Member] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Cover [Abstract] Document Information [Line Items] Document Quarterly Report Amendment Flag Title and Position [Axis] Title and Position [Domain] Director [Member] Director [Member] Executive Officer [Member] Executive Officer [Member] Common stock issuable upon conversion of Series B-1 convertible preferred stock Common Stock Issuable Upon Conversion Of Series B 1 Convertible Preferred Stock [Member] Warrant Liability - Schedule of Preferred Stock Warrants (Details) [Table] Number of Shares Underlying Outstanding Warrants, Outstanding at Beginning Number of Shares Underlying Outstanding Warrants, Outstanding at Ending Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Number Of Shares Underlying Outstanding Warrants Outstanding The number of outstanding equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. StatementOfIncomeDomain [Domain] General and administrative [Member] General And Administrative Member Total stock-based compensation Share-Based Payment Arrangement, Expense Schedule Of Fair Value Of Awards Granted Abstract Statistical Measurement [Axis] Minimum [Member] Minimum [Member] Schedule of Fair Value of Awards Granted [Line Items] Schedule of Valuation Inputs into the Black Scholes Model for the Liability [Line Items] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Net (loss) attributable to common shares, basic Net Income (Loss) Available to Common Stockholders, Basic Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, diluted (in Shares) Weighted-average shares outstanding used in computing net (loss) per share, diluted (in Shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, basic (in Shares) Weighted-average shares outstanding used in computing net (loss) per share Weighted Average Number of Shares Outstanding, Basic Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities, Name [Domain] Warrants to purchase convertible preferred stock [Member] Warrants To Purchase Convertible Preferred Stock Member Antidilutive Securities Anti-dilution shares of common stock (in Shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Tranche B Warrant [Member] Share-Based Payment Arrangement, Tranche Two [Member] Document Fiscal Year Focus Measurement Input Type [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Net (loss) per share attributable to common stockholders, basic (in Dollars per share) Net loss per share attributable to common stockholders, basic (in Dollars per share) Earnings Per Share, Basic Schedule of Outstanding Shares of Potentially Dilutive Securities [Abstract] Antidilutive Securities [Axis] Options to purchase common stock [Member] Restricted Stock Units [Member] Restricted Stock Units Member Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock [Member] Common Stock Issuable Upon Conversion Of Series A2 Prime Convertible Preferred Stock Member Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items] Tranche C Warrant [Member] Share-Based Payment Arrangement, Tranche Three [Member] Warrants measurement inputs Warrants and Rights Outstanding, Measurement Input Recognized period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Stock options, proceeds (in Dollars) Proceeds from Stock Plans Vested portion options (in Dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Annual net cash flow from operations percentage Annual Net Cash Flow From Operations Percentage Annual net cash flow from operations percentage. Entity Central Index Key Current Fiscal Year End Date Entity Address, Address Line One Entity Address, City or Town City Area Code Weighted- Average Exercise Price, Outstanding at Ending Weighted- Average Exercise Price, Outstanding at Beginning Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Outstanding The weighted average fair value at outstanding date for equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Aggregate Intrinsic Value, Warrants issuable Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Warrants Issued Intrinsic value of warrant issued award under share-based payment arrangement. Excludes share and unit options. Schedule Of Activity For Stock Options Abstract Current liabilities: Liabilities, Current [Abstract] Common stock, $0.001 par value per share – 400,000,000 shares authorized at December 31, 2025, and June 30, 2026; 22,114,245 and 27,855,257 shares issued and outstanding at December 31, 2025, and June 30, 2026, respectively Common Stock, Value, Issued Organization and Description of Business [Line Items] Accumulated deficit Retained Earnings (Accumulated Deficit) Proceeds from private placement Proceeds from Issuance of Private Placement Preferred stock, value Investors of convertible preferred stock Preferred Stock, Value, Issued Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total liabilities and stockholders’ equity Liabilities and Equity Statement of Financial Position [Abstract] Warrant liability Fair value opening balance Fair value ending balance Warrants and Rights Outstanding Total current liabilities Liabilities, Current Total liabilities Liabilities Stockholders’ equity: Equity, Attributable to Parent [Abstract] Statement [Line Items] Income Statement [Abstract] Research and development Research and Development Expense Total operating expenses Operating Expenses Summary of Significant Accounting Policies [Abstract] Conversion of Series A-3 preferred stock into common stock Stock Issued During Period Value Conversion of Series A-3 Preferred Stock into Common Stock The amount of conversion of Series A-3 preferred stock into common stock. Conversion of Series A-3 preferred stock into common stock (in shares) Stock Issued During Period Shares Conversion of Series A-3 Preferred Stock into Common Stock The number of conversion of Series A-3 preferred stock into common stock. Issuance of common stock for vested restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Gross Issuance of common stock for vested restricted stock units (in shares) Share of restricted stock Stock Issued During Period, Shares, Restricted Stock Award, Gross Proceeds from exercise of warrants Proceeds from Warrant Exercises Rule 10b5-1 Arrangement Modified Rule 10b5-1 Arrangement Modified. Non-Rule 10b5-1 Arrangement Modified Non-Rule 10b5-1 Arrangement Modified. Entity Interactive Data Current Net Loss Per Share Earnings Per Share [Text Block] Subsequent Events [Abstract] Total cash, cash equivalents and investments in marketable securities Total Cash Cash Equivalents And Investments In Marketable Securities Member [Member] Cash and Cash Equivalents [Domain] Corporate Bonds [Member] Corporate Bonds Member Fair Value by Liability Class [Domain] Warrant Liability [Member] Warrant Liability Member Interest expense Interest Expense, Nonoperating Total other income (expenses) Nonoperating Income (Expense) Organization and Description of Business Nature of Operations [Text Block] Cash, Cash Equivalents, and Marketable Securities Cash, Cash Equivalent, and Marketable Security [Text Block] Significant Agreements [Abstract] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Operating Lease [Abstract] Warrant Liability Warrant Liability Disclosure Text Block The entire disclosure of warrant and liabilities. Trading Symbol Title of 12(b) Security Preferred stock, shares issued (in Shares) Preferred stock shares issued Preferred Stock, Shares Issued Statement [Table] Preferred stock, par value (in Dollars per share) Preferred Stock, Par or Stated Value Per Share Operating expenses: Operating Expenses [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Deferred insurance charges included in prepaid expenses and other current assets Deferred Insurance Charges Included In Prepaid Expenses And Other Current Assets The amount of deferred insurance charges included in prepaid expenses and other current assets. Schedule of Changes in Fair Value of the Warrant Liability Classified in Level 3 Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Cash, Cash Equivalents, and Marketable Securities [Abstract] Schedule of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Schedule of Accounts Payable Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Gross proceeds from secondary public offering Proceeds From Issuance Secondary Public Offering The cash inflow associated with the amount received from entity's secondary offering of stock to the public. Payments on financed insurance policies Payments of Financing Costs Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Warrant Liability [Abstract] Schedule of Preferred Stock Warrants Schedule Of Issuable Preferred Stock Warrants Table Text Block Tabular disclosure of schedule of issuable preferred stock warrants. Schedule of Maturities of Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Activity for the Company’s IPO Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Fair Value Hierarchy and NAV [Axis] Net comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Issuance of Series A-3 preferred stock upon exercise of warrants Stock Issued During Period Value Issuance of Series A-3 Preferred Stock Upon Exercise of Warrants The amount of Issuance of Series A-3 preferred stock upon exercise of warrants. Issuance of Series A-3 preferred stock upon exercise of warrants (in shares) Stock Issued During Period Shares Issuance of Series A-3 Preferred Stock Upon Exercise of Warrants The number of Issuance of Series A-3 preferred stock upon exercise of warrants. Conversion of Series B-2 preferred stock into common stock Stock Issued During Period Value Conversion of Series B-2 Preferred Stock into Common Stock The amount of Conversion of Series B-2 preferred stock into common stock. Conversion of Series B-2 preferred stock into common stock (in shares) Stock Issued During Period Shares Conversion of Series B-2 Preferred Stock into Common Stock The number of conversion of series B-2 preferred stock into common stock. Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Warrant Liability Warrant Liability Policy Text Block The disclosure of accounting policy for warrant liability. Risks and Uncertainties Risks And Uncertainties Policy Text Block Disclosure of accounting policy for risks and uncertainties. Leases Lessee, Leases [Policy Text Block] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Issuance of Series A-1 Preferred Stock Preferred Stock [Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Patent Costs Patent Costs Policy Text Block Disclosure of accounting policy for patent costs. Schedule Of Company SInvestments Abstract Asset Class [Axis] Investments in corporate bonds [Member] Investments In Corporate Bonds Member Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Schedule of Valuation Inputs into the Black Scholes Model for the Liability Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of Remaining Lease Term and Discount Rates Lease, Cost [Table Text Block] Schedule of Activity for Stock Options Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Fair Value of Awards Granted Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) [Table] Net Loss Per Share [Abstract] Schedule of Outstanding Shares of Potentially Dilutive Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Fair Value Hierarchy and NAV [Domain] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Abstract] Accrued liabilities Total Accrued Liabilities, Current Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Balance Balance Total stockholders’ equity Equity, Attributable to Parent Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Purchases of marketable securities Payments to Acquire Marketable Securities Realized gain on marketable securities Marketable Security, Unrealized Gain (Loss) Initial recognition of right-of-use assets and corresponding lease liabilities New Lease Right Of Use Asset New lease right of use asset. Schedule of Company’s Investments Investment [Table Text Block] Balance Sheet Components [Abstract] Schedule of Property and Equipment Property, Plant, and Equipment [Table Text Block] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Commissions paid on secondary public offering Commissions Paid On Settlement The amount of commissions paid on settlement. Other income (expenses): Nonoperating Income (Expense) [Abstract] Net loss per share attributable to common stockholders, diluted (in Dollars per share) Net (loss) per share attributable to common stockholders, diluted (in Dollars per share) Earnings Per Share, Diluted Significant Agreements Significant Agreement Text Block The entire disclosure for significant agreements. Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Operating Lease Lessee, Operating Leases [Text Block] Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock Issuance Of Series B1 Preferred Stock Text Block The disclosure of issuance of series b1 preferred stock. Delaware [Member] DELAWARE Related Party Transaction [Domain] Security Exchange Name Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Member] Cash And Cash Equivalent Member Liability Class [Axis] Related Party Transaction [Axis] Initial Institutional Investors [Member] Initial Institutional Investors Member Incorporation date Entity Incorporation, Date of Incorporation Net proceeds Aggregate net proceeds (in Dollars) Proceeds from Issuance Initial Public Offering Offering price Sale of Stock, Consideration Received on Transaction Common stock average price share (in Dollars per share) Purchase price Sale of Stock, Price Per Share Gross proceeds Proceeds from Issuance of Common Stock Long-Lived Asset, Class [Axis] Lab Equipment [Member] Office Equipment [Member] Summary of Significant Accounting Policies [Line Items] Fixed assets net book value Fixed Assets Net Book Value Amount of fixed assets net book value. Private Placement [Member] Private Placement [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Geographical [Axis] Tax benefit settlement, percentage Effective Income Tax Rate Reconciliation, Tax Settlement, Percent Cash, Cash Equivalents, and Marketable Securities (Details) [Table] Entity Registrant Name Entity Tax Identification Number Entity Filer Category Entity Shell Company Entity Ex Transition Period Entity Incorporation, State or Country Code Local Phone Number Net proceeds Net Proceeds Net proceeds. Payments for commissions Payments for Commissions Summary of Significant Accounting Policies (Details) [Table] Long-Lived Asset, Class [Domain] Cash payments on lease Operating Lease, Payments Amortization of right-of-use asset Amortization of operating lease right of use asset Operating Lease, Right-of-Use Asset, Periodic Reduction Amortization of Right-of-Use Asset [Member] Amortization Of Rightof Use Asset Member Present value of lease liability Lease liability Operating Lease, Liability Long term portion Operating lease liability – long term Operating Lease, Liability, Noncurrent Trade accounts payable Accounts Payable, Trade, Current Total Accounts payable Accounts Payable, Current Schedule of Accrued Liabilities [Abstract] Accrued drug development costs Accrued Drug Development Costs Current The amount of accrued drug development costs. Schedule of Prepaid Expenses and Other Current Assets [Abstract] Year ending December 31, 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Schedule of Maturities of Lease Liabilities [Abstract] Significant Agreements (Details) [Table] Schedule of Remaining Lease Term and Discount Rates [Abstract] Incremental borrowing rate Operating Lease, Weighted Average Discount Rate, Percent Remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Maximum [Member] Maximum [Member] Statistical Measurement [Domain] Commitments and Contingencies (Details) [Table] Aggregate exercise price (in Dollars) Aggregate Exercise Price Represent the amount of aggregate exercise price. Exchange Agreement [Member] Exchange Agreement Member Issuance of Series A-1 Preferred Stock [Abstract] Series A-1 Preferred Stock [Member] Series A1 Preferred Stock Member Series A-4 Preferred Stock [Member] Series A4 Preferred Stock Member Series A Certificate of Designation [Member] Series ACertificate Of Designation Member Series A-3 Convertible Preferred Stock [Member] Series A3 Convertible Preferred Stock Member Series A-5 Convertible Preferred Stock [Member] Series A5 Convertible Preferred Stock Member Shareholder [Member] Shareholder Member Voting share of common stock Common Stock, Voting Rights Divided shares Common Stock Dividends, Shares Warrant Liability (Details) [Table] Tranche A Warrant [Member] Tranche AWarrant Member Tranche C Warrant [Member] Tranche CWarrant Member Series B Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Series B Preferred Stock [Member] Series B Certificate of Designation [Member] Series BCertificate Of Designation Member Gross proceed Proceed From Issuance Of Preferred Stock The cash inflow from issuance of preferred stock. Annual rate Annual Rate Percentage The percentage of annual rate percent. Issuance of Series A-1 Preferred Stock (Details) [Table] Series A Preferred Stock [Member] Series A Preferred Stock [Member] Series A-4 Convertible Preferred Stock [Member] Series A4 Convertible Preferred Stock Member Series A-2 Prime Convertible Preferred Stock [Member] Series A2 Prime Convertible Preferred Stock Member Issuance of Series A-1 Preferred Stock [Line Items] Conversion price (in Dollars per share) Conversion price Preferred Stock, Convertible, Conversion Price Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock (Details) [Table] Series B-1 Preferred Stock [Member] Series B1 Preferred Stock Member Aggregate offering costs (in Dollars) Preferred Units, Offering Costs Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Share issued Issuance of common stock for cash, net of issuance costs (in Shares) Issued of common shares (in Shares) Stock Issued During Period, Shares, New Issues Securities Purchase Agreement [Member] Securities Purchase Agreement Member Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items] Proceed amount Proceeds from Issuance of Convertible Preferred Stock Original Tranche C Warrants [Member] Original Tranche CWarrants Member Number of shares reserved Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Number of Shares, Period Increase (Decrease) Available under plan Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Weighted- Average Remaining Contractual Term (in Years), Outstanding at Ending Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms2 Weighted- Average Remaining Contractual Term (in Years). Weighted- Average Exercise Price, Warrants exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Warrants Exercised The weighted average fair value at warrants exercised for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Stock-Based Compensation - Schedule of Activity for Stock Options (Details) [Table] Weighted-Average Exercise Price, Options vested and exercisable (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Aggregate Intrinsic Value, Outstanding, Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Weighted-Average Remaining Contractual Term (in Years), Options forfeited Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Termin Years Options Forfeited Number of shares weighted-average remaining contractual term, options forfeited. Number of Shares Underlying Outstanding Options, Options exercised (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Weighted-Average Remaining Contractual Term (in Years), Options exercised Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted-Average Exercise Price Ending (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Aggregate Intrinsic Value Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Shareholders [Member] Shareholders Member Weighted- Average Exercise Price, Warrants contingently issuable Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Warrants Issued The number of warrants issued equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Numerator: Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent [Abstract] Document Information [Table] Document Type Document Transition Report Schedule of Basic and Diluted Net Loss Per Share [Abstract] Fair Value Measurement Inputs and Valuation Techniques [Table] Term (in years) [Member] Measurement Input, Expected Term [Member] Fair Value of Underlying Stock [Member] Measurement Input, Appraised Value [Member] Volatility [Member] Measurement Input, Price Volatility [Member] Probability for FDA approval [Member] Measurement Input Probability For FDAApproval Member Tranche A Warrant [Member] Share-Based Payment Arrangement, Tranche One [Member] Schedule of Preferred Stock Warrants [Line Items] Research and development [Member] Research And Development Member Schedule of Stock-Based Compensation Expense [Line Items] Stock-Based Compensation - Schedule of Fair Value of Awards Granted (Details) [Table] Schedule Of Valuation Inputs Into The Black Scholes Model For The Liability Abstract Dividend yield [Member] Measurement Input, Expected Dividend Rate [Member] Discount for lack of marketability [Member] Measurement Input, Discount for Lack of Marketability [Member] Measurement Input Type [Axis] Exercise price [Member] Measurement Input, Exercise Price [Member] Risk free rate [Member] Measurement Input, Risk Free Interest Rate [Member] Derivative Instrument [Axis] Number of Shares Underlying Outstanding Options, Options vested and exercisable (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Weighted-Average Remaining Contractual Term (in Years), Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value, Options granted Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value Represent the amount of share based compensation arrangement by share based payment award options granted intrinsic value. Aggregate Intrinsic Value, Options forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Options Forfeited The amount of aggregate intrinsic value, options forfeited. Weighted-Average Exercise Price, Options exercised (in Dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Number of Shares Underlying Outstanding Options Ending (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Weighted-Average Remaining Contractual Term (in Years) Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value, Options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Schedule Of Stock Based Compensation Expense Abstract Statement of Income [Axis] Statement Of Income Axis Number of Shares Underlying Outstanding Warrants, Warrants contingently issuable Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Number Of Shares Underlying Outstanding Warrants Issued The number of Warrants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Weighted- Average Remaining Contractual Term (in Years), Warrants contingently issuable Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Remaining Contractual Termin Years Warrants Issued The number of warrants issued equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Unrecognized compensation cost (in Dollars) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Exercised stock options Exercised Stock Option Number of share options exercised stock option. Options remained unvested Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Fair value per share (in Dollars per share) Option Contract Indexed to Equity, Settlement, Share, Fair Value Per Share Entity Address, Address Line Two Entity Address, State or Province Entity Address, Postal Zip Code Denominator: Weighted Average Number of Shares Outstanding, Basic [Abstract] Altair Nanomaterials, Inc [Member] Altair Nanomaterials Inc Member Statement of Stockholders' Equity [Abstract] Additional Paid-In Capital Additional Paid-in Capital [Member] Comprehensive Loss AOCI Attributable to Parent [Member] Conversion of Series A-2 Prime preferred stock into common stock Conversion of Stock, Amount Converted Maturities of marketable securities The amount of maturities of marketable securities. Altair [Member] Altair Member Lotus International Pte Ltd [Member] Lotus International Pte Ltd Member Investment, Name [Domain] Agreement due payments Agreement Due Payments Amount of agreement due payments . Prepaid expenses and other current assets Total Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization General and administrative General and Administrative Expense Loss from operations Operating Income (Loss) Common stock, shares outstanding (in Shares) Common Stock, Shares, Outstanding Interest income Investment Income, Interest Change in fair value of warrant liability Change in fair value of warrants Change in fair value of warrant liability Fair Value Adjustment of Warrants Net loss Net loss Unrealized loss on marketable securities, net OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Organization and Description of Business [Abstract] U.S. Treasury Bills [Member] US Treasury Bill Securities [Member] Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Company’s Investments [Line Items] Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Cash, Cash Equivalents, and Marketable Securities [Line Items] Investments Investments Exclusive license agreement [Member] Exclusive License Agreement Member Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Estimated Fair Value Debt Securities, Available-for-Sale, Noncurrent Stock-based Compensation Share-Based Payment Arrangement [Text Block] Subsequent Events Subsequent Events [Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Stockholders’ Equity Equity [Text Block] Marketable Securities Marketable Securities, Policy [Policy Text Block] Segment Information Segment Reporting, Policy [Policy Text Block] Property and Equipment Property, Plant, and Equipment [Policy Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Prepaid Expenses and Other Current Assets Prepaid Expenses Policy Text Block Disclosure of accounting policy for prepaid expenses. General and Administrative Expenses Selling, General and Administrative Expenses, Policy [Policy Text Block] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Accumulated Other Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Cash, Cash Equivalents, and Marketable Securities - Schedule of Company’s Investments (Details) [Table] Issuance of common stock for cash, net of issuance costs Common stock valued Stock Issued During Period, Value, New Issues Unrealized loss on marketable securities, net OCI, Debt Securities, Available-for-Sale, Transfer from Held-to-Maturity, Gain (Loss), before Adjustment, after Tax Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Loss on disposal of assets Gain (Loss) on Disposition of Assets Amortization of investments in marketable securities Increase Decrease In Discount On Investments In Marketable Securities Amount of increase (decrease) in discount on investments in marketable securities. Prepaid expense and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Operating lease liability Increase (Decrease) in Operating Lease Liability Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Balance (in Shares) Balance (in Shares) Shares, Outstanding Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Operating lease liability - current Less current portion Operating Lease, Liability, Current Additional paid-in capital Additional Paid in Capital Commitments and contingencies (Note 7) Commitments and Contingencies Schedule of Fair Value Hierarchy of Financial Liabilities Measured at Fair Value [Line Items] Total marketable securities at fair value Marketable securities Marketable Securities, Current Schedule Of Changes In Fair Value Of The Warrant Liability Classified In Level3 Abstract Schedule of Changes in Fair Value of the Warrant Liability Classified in Level 3 [Line Items] Cash [Member] Cash [Member] Other comprehensive loss: Other Comprehensive Income (Loss), Tax [Abstract] Total cash and cash equivalents at fair value Cash and Cash Equivalents, Fair Value Disclosure Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Total liabilities at fair value Liabilities, Fair Value Disclosure Amortized Cost Basis Debt Securities, Available-for-Sale, Amortized Cost Money Market [Member] Money Market Funds [Member] Lee’s Pharmaceutical (HK) Limited [Member] Lees Pharmaceutical HKLimited Member Investment, Name [Axis] Investment [Member] Investment Member Asset Class [Domain] Cash and cash equivalents Cash and Cash Equivalent Right of use asset, net Operating Lease, Right-of-Use Asset Total assets Assets Geographical [Domain] Organization and Description of Business (Details) [Table] Guggenheim Securities LLC [Member] Guggenheim Securities LLCMember Comprehensive income Other Comprehensive Income (Loss), Tax Entity Current Reporting Status Entity File Number Entity Emerging Growth Company Entity Small Business Entity Common Stock, Shares Outstanding Current assets: Assets, Current [Abstract] Accumulated Deficit Retained Earnings [Member] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Statement of Cash Flows [Abstract] Depreciation expense Depreciation Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Changes in assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Furniture and Fixtures [Member] Furniture and fixtures [Member] Furniture and Fixtures [Member] Property and equipment estimated useful lives Property, Plant, and Equipment, Useful Life Spectrum Agreement [Member] Spectrum Agreement Member Net sales percentage Royalty Percentage Percentage of royalty payment. Payment amount Payment Amount The total payment amount. Lease Contractual Term [Axis] Public market capitalization Capitalization, Long-Term Debt and Equity Research and development expenses Other Research and Development Expense Sublicense income granted percentage Sub License Income Granted Percentage Sub license income granted percentage. Significant payment received Significant Payment Received Significant payment received. Operating lease [Member] Operating Lease Member Square feet of office space (in Square Feet) Area of Land Initial lease term Lessee, Operating Lease, Term of Contract Lease Liability [Member] Lease Liability Member Less imputed interest rate / present value discount Lessee, Operating Lease, Liability, Undiscounted Excess Amount Other Other Prepaid Expense, Current Property, Plant, and Equipment [Table] Prepaid drug manufacturing supply costs Prepaid Supplies Schedule Of Property And Equipment Abstract Leasehold improvements [Member] Leasehold Improvements [Member] Subtotal Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Schedule of Accounts Payable [Abstract] Credit card liability Other Liabilities, Current Accrued labor costs Accrued Salaries, Current Prepaid directors’ and officers’ liability insurance premiums Prepaid Insurance Total lease payments Lessee, Operating Lease, Liability, to be Paid Other Other Accrued Liabilities, Current Year ending December 31, 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Sublicense Development Agreement [Member] Sublicense Development Agreement Member Lab equipment [Member] Equipment [Member] Schedule of Property and Equipment [Line Items] Less accumulated depreciation Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Shilpa Medicare Ltd [Member] Shilpa Medicare Ltd Member Significant Agreements [Line Items] Second clinical trial payment Second Clinical Trial Payment The amount of second clinical trial payment. Interest on ownership Equity Method Investment, Ownership Percentage Royalties percentage Royalties Percentage Percentage of royalties. Operating Lease (Details) [Table] Lease Contractual Term [Domain] Required to pay Other Expenses Sublicense income percentage Sublicense Income Percentage Sublicense income percentage. Milestone payments Milestone Payments Amount of milestone payments. Operating Lease [Line Items]